Samuel G. Taylor
#144,124
Most Influential Person Now
Samuel G. Taylor's AcademicInfluence.com Rankings
Samuel G. Taylormedical Degrees
Medical
#2678
World Rank
#3109
Historical Rank
Oncology
#172
World Rank
#178
Historical Rank
Download Badge
Medical
Why Is Samuel G. Taylor Influential?
(Suggest an Edit or Addition)Samuel G. Taylor's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Head and neck cancer. (1991) (3275)
- Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. (1999) (437)
- Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. (1988) (209)
- Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. (1994) (194)
- Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. (1984) (191)
- Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. (1989) (175)
- Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L‐phenylalanine mustard (1976) (171)
- Treatment of cerebral metastases from breast carcinoma with prednisolone. (1957) (128)
- A randomized trial of adjuvant chemotherapy in head and neck cancer. (1985) (116)
- Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. (1987) (105)
- Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients. (1993) (105)
- Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. (1989) (104)
- Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women. (1986) (103)
- Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trial. (1993) (97)
- Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer. (1998) (76)
- Clinical study with bleomycin (1971) (66)
- Stage-IIB osteosarcomas around the knee. A study of MMP-9 in surviving tumour cells. (2002) (62)
- Cortical steroids in treatment of cancer; observations on effects of pituitary adrenocorticotropic hormone (ACTH) and cortisone in far advanced cases. (1950) (61)
- Mithramycin therapy in disseminated germinal testicular cancer. (1968) (57)
- Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. (1987) (55)
- Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review. (1981) (53)
- Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. (1989) (52)
- Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report. (1999) (50)
- Concomitant cisplatin/5‐FU infusion and radiotherapy in advanced head and neck cancer: 8‐year analysis of results (1997) (50)
- A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer. (1984) (49)
- Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. (1985) (47)
- Toxic reactions of 4‐amino‐pteroylglutamic acid (aminopterin) in patients with far‐advanced neoplastic disease (1950) (47)
- Surgical complications in patients with head and neck cancer receiving chemotherapy. (1986) (47)
- Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an Eastern Cooperative Oncology Group Pilot Study. (1986) (46)
- Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study. (1985) (42)
- Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer. (1986) (40)
- The use of prednisolone in the treatment of disseminated breast carcinoma (1958) (39)
- Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. (1991) (34)
- The role of corticosteroids in the treatment of malignant lymphomas (1962) (34)
- Why has so much chemotherapy done so little in head and neck cancer? (1987) (29)
- Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma. (1987) (29)
- Streptozotocin therapy for metastatic insulinoma. (1970) (29)
- The effect of sex hormones on advanced carcinoma of the breast (1948) (29)
- Methotrexate compared with placebo in lung cancer (1977) (28)
- Clinical use of 6‐aminonicotinamide in patients with disseminated neoplastic disease (1961) (28)
- Mutation of p53 in Squamous Cell Cancer of the Head and Neck: Relationship to Tumor Cell Proliferation (1997) (28)
- Combined modality therapy for locally advanced non‐small cell lung carcinoma (1990) (27)
- Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation. (1994) (26)
- Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure. (1992) (25)
- Chemotherapy for squamous cell carcinoma of the head and neck: a progress report. (1980) (24)
- Pilot Study for the Evaluation of Simultaneous Cisplatin/5‐Fluorouracil Infusion and Limited Radiation Therapy in Regionally Recurrent Head and Neck Cancer (EST P‐C385) (1994) (24)
- Integration of chemotherapy into the combined modality therapy of head and neck squamous cancer. (1987) (24)
- A randomized trial of adjuvant BCG immunotherapy in head and neck cancer. (1983) (23)
- The use of strontium-85 in the evaluation of bone metastases. A preliminary report. (1963) (21)
- Endocrine ablation in disseminated mammary carcinoma. (1962) (20)
- In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non‐involved mucosa of head and neck region (1995) (19)
- Hormonal modification in the treatment of disseminated cancer of the breast. (1956) (19)
- Phase II trial of etoposide, cisplatin, continuous infusion 5-fluorouracil, and simultaneous split-course radiation therapy in stage III non-small-cell bronchogenic carcinoma. (1986) (18)
- Adjuvant methotrexate and leucovorin in head and neck squamous cancer. Two-year follow-up of a pilot project. (1978) (18)
- Hormones in breast metastasis therapy. (1951) (18)
- Biochemical effects of mithramycin on cultured cells. (1969) (17)
- EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS. (1963) (17)
- Retrospective analysis of hyperthermia for use in the palliative treatment of cancer: a multi-modality evaluation. (1990) (16)
- Integration of surgery in multimodality therapy for esophageal cancer. (1997) (14)
- Clinical studies of 5-fluorouracil + premarin in the treatment of breast cancer. (1975) (14)
- Preoperative radiation therapy in regionally localized stage III non-small cell lung carcinoma: long-term results and patterns of failure. (1990) (14)
- Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). (1974) (13)
- Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy. (1996) (13)
- Critical analysis of palliation produced by adrenalectomy in metastatic cancer of the female breast. (1956) (13)
- Regrowth resistance as a likely significant contributor to treatment failure in drug-sensitive neoplastic diseases. (1997) (12)
- Modulation of immunity in cancer patients by prostaglandin antagonists. (1989) (12)
- PALA in advanced breast cancer A phase II pilot study by the ECOG (1982) (11)
- Adjuvant chemoimmunotherapy of head and neck cancer. (1978) (10)
- Combined modality treatment using BID radiation for locally advanced non‐small cell lung carcinoma (1994) (10)
- Modification of the effects of cytotoxic chemotherapy on the immune responses of cancer patients with a nonsteroidal, antiinflammatory drug, piroxicam. A pilot study of the Eastern Cooperative Oncology Group. (1987) (9)
- Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel. (1975) (9)
- Chemotherapy of cancer. (1950) (9)
- Phase I clinical trial of a single-dose and two weekly schedules of ICRF-159 (NSC-129943). (1974) (9)
- Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in stage III non-small cell lung cancer. (1988) (8)
- An evaluation of ovarian status as a prognostic factor in disseminated cancer of the breast (1970) (8)
- Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma. (1988) (8)
- Effect of antifolic acid derivatives on patients with far-advanced carcinomatosis. (1948) (7)
- Experience of the Eastern Cooperative Oncology Group with doxorubicin as a single agent in patients with previously untreated breast cancer. (1982) (7)
- The incorporation of formate-C14 into human breast cancer in vitro. (1960) (7)
- The effect of testosterone propionate on metastases to bone from carcinoma of the breast. (1949) (7)
- TG cell involvement in the leukocyte adherence inhibition phenomenon. (1982) (7)
- Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441). (1975) (6)
- THE TREATMENT OF ADDISON'S DISEASE WITH ADRENAL CORTEX EXTRACT1 (1939) (6)
- Antigen specificity of squamous cancers of the head and neck based on tumor site using the slide leukocyte adherence inhibition assay (1982) (5)
- Combination chemotherapy pilot studies in head and neck squamous cell cancer. (1979) (5)
- Hormonal treatment of breast cancer. (1963) (5)
- A randomized comparison of two dosage schedules of methyl CCNU: Three‐week versus six‐week treatments (1979) (5)
- Cancer and the internist. (1966) (5)
- Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer. (1985) (4)
- Adriamycin: comparison of a 5-week schedule with a 3-week schedule in the treatment of breast cancer. (1979) (4)
- Head and neck cancer. (1994) (4)
- Assessment of apoptosis in relation to proliferation and mutational status of p53 gene in head and neck cancers. (1996) (4)
- Bleomycin in combination chemotherapy of metastatic Wilms tumor: a late recurrent case, refractory to conventional therapy. (1979) (4)
- Postmenopausal node-positive comparison of observation with CMFP and CMPF + tamoxifen adjuvant therapy: an Eastern Cooperative Oncology Group trial. (1984) (3)
- Effect of surgical Addison's disease on advanced carcinoma of the breast and prostate. (1953) (3)
- A correlation between the incorporation of formate‐C14 in tumors and the clinical course of patients with disseminated breast cancer (1960) (3)
- The physician and the cancer patient. (1952) (3)
- Concomitant therapy with infusion of cisplatin and 5-fluorouracil plus radiation in head and neck cancer. (1988) (2)
- Lymphocyte responsiveness to thymosin in angioimmunoblastic lymphadenopathy with lymphomatous transformation. (1982) (2)
- Controversies in the multimodality management of head and neck cancer. (1991) (2)
- Treatment of far-advanced inoperable carcinoma of the breast with estrogens and androgens. (1948) (2)
- Adriamycin, vincristine, dibromodulcitol, and hexamethylmelamine in advanced previously treated breast cancer: an ECOG pilot study. (1981) (2)
- Endocrine therapy in the aged patient. (1956) (1)
- Phase II trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma. (1978) (1)
- FURTHER OBSERVATIONS ON THE THYROTROPIC ACTIVITY OF THE ANTERIOR PITUITARY (1942) (1)
- Effect of ACTH and cortisone on advanced malignant disease. (1950) (1)
- Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule. (1975) (1)
- Palliative treatment of head and neck squamous cancer with cisplatin and hydroxyurea. (1984) (1)
- PANEL DISCUSSION ON THE PALLIATION OF ADVANCED CANCER IN THE OLDER AGE GROUPS † (1957) (1)
- Continuous infusion of etoposide, bolus administration of cisplatin, and simultaneous radiation therapy in previously treated patients with small cell bronchogenic carcinoma. (1988) (1)
- THE EFFECT OF HEATING WITH ALKALI ON THE CALORIGENIC ACTIVITY OF DESICCATED THYROID AND OF THYROXINE. (1937) (0)
- Factor influencing effects of bilateral adrenalectomy on carcinoma of the breast. (1955) (0)
- Head and neck cancer. (1992) (0)
- Head and neck cancer. (2001) (0)
- Combined chemotherapy and radiation for unresectable head and neck cancer. (1990) (0)
- O2212 STAGE IIB KNEE OSTEOSARCOMAS. A STUDY OF MMP-9 IN SURVIVING TUMOUR CELLS (2004) (0)
- Chemotherapy of head and neck cancer. (1996) (0)
- Role of the internist in cancer. (1960) (0)
- Head and neck cancer. (1993) (0)
- MEDICAL MANAGEMENT IN CARCINOMA OF THE BREAST. (1964) (0)
- Effect of resuspended erythrocyte transfusion on serum protein. (1946) (0)
- Cancer and the internist (1966) (0)
- Pilot Study of Adriamycin and Amsacrine (m‐AMSA) in Patients with Advanced Breast Cancer (1988) (0)
- COLON CANCER. (1964) (0)
- Antitumor effect of a mycobacterial rna fraction and bcg in three murine models. Abstr. (1977) (0)
- Effects of estrogens on the incorporation of C14 formate into human breast cancer (1958) (0)
- Head and neck cancer. (1987) (0)
- Head and Neck Cancer (2003) (0)
- Head and neck cancer. (1990) (0)
- Disseminated breast carcinoma. Some aspects in management. (1963) (0)
- Use of chemotherapy to cure head and neck cancer. (1995) (0)
- Granulocytopenia from the combined use of thiouracil and sulfonamides. (1946) (0)
- Head and neck cancer. (1999) (0)
- Head and neck cancer. (1988) (0)
- Randomized comparison of neoadjuvant cisplatin and fluorouracil infustion followed by radiation versus concomitant treatment in advanced head and neck cancer. In Class Papers and Current Comments, Head and Neck Cancer Research (1999) (0)
- Cancer and the chemotherapist. (1963) (0)
- Role of the internist in cancer (1960) (0)
- The influences of the pituitary in thyroid disease. (1938) (0)
- Common medical problems in disseminated cancer. (1970) (0)
- The systemic therapy of breast cancer. (1978) (0)
- Modulation of lymphokine activated killer lak cell induction following cytotoxic chemotherapy (1987) (0)
- Examination of the breast. (1962) (0)
- Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer. (1984) (0)
- BIOCHEMICAL APPROACH TO CANCER SURGERY. ENDOCRINE ABLATIVE SURGERY. (1963) (0)
- Selection of treatment for lymphoma. (1973) (0)
- Treatment of toxic goiter with propyl-thiouracil. (1947) (0)
This paper list is powered by the following services:
